Pharmadule brings Modular Concept to ISPE 2014 Frankfurt
Press Release | Pharmadule Morimatsu AB
APRIL 03, 2014
Nacka, Stockholm: – Swedish-based designer and builder of modular production facilities for the pharma and biopharma industries, Pharmadule Morimatsu AB (Pharmadule) will exhibit its distinctive modular approach to design/build at the leading European Pharmaceutical Engineering event, ISPE Annual Conference 2014 in Frankfurt this month.
Pharmadule Morimatsu will be hosting a table top exhibition at this influential conference on April 28-30.
“As one of the world-leading companies in supplying modular production facilities for the pharma and biotech industry, ISPE Europe is a very important event for us,” commented Ulf Danielsson, Pharmadule Morimatsu Executive Vice President, Sales & Marketing.
“The International Society for Pharmaceutical Engineering is an organization that does great work in our industry and we attend almost all their conferences, most recently one held in Stockholm in November last year,” said Mr. Danielsson.
“This is an important information sharing and networking opportunity and we will be using it to communicate the advantages of our products and services and to identify emerging new trends by meeting pharmaceutical, regulatory and technology experts from around the world,” he added.
“We will be particularly interested in the Facilities of the Future track, since that future almost certainly belongs to “adaptable” and flexible designs and facilities of the kind that we have pioneered,” said Mr. Danielsson.
Pharmadule Morimatsu will be located at Table 35 at the table top exhibition at Sheraton Conference Centre, prepared to provide details of its offerings, including design and construction services, modular off-site production solutions, commissioning and qualification expertise and GMP consultancy.
The company will also be using the exhibition’s networking opportunities to identify forthcoming project leads and partners, reaching out to executive and senior managers in engineering & facilities, process technology, process science and operations/facility development.
About Pharmadule Morimatsu
Pharmadule Morimatsu designs and builds turnkey production facilities for the pharma and biopharma Industries. Pharmadule services extend from conceptual design to IQ/OQ completion, offering a one-stop-shop suite of services that include: Facility Design and Engineering, Process Design and Engineering, Project Management, Fabrication, Quality Assurance and Commissioning and Qualification Management.
The company was founded in 1986, since which time it has successfully delivered more than 60 production facilities worldwide for clients including Eli Lilly, Merck, Baxter, GlaxoSmithKline, Genentech, Pharmacia and AstraZeneca. In forging The Pharmadule Way to offer unique value and reassurance to customers, with off-site construction and modular design concepts, Pharmadule provides very high predictability of on time, on budget delivery and consistent high quality, regardless of the final project location.
Pharmadule is now part of the Morimatsu Group of Japan, forming Pharmadule Morimatsu AB, headquartered in Stockholm, Sweden. The company also has a strong presence in Asia with engineering and manufacturing facilities in Shanghai, providing an enhanced service for clients in new markets.
About ISPE 2014
ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association in this arena, committed to the advancement of the educational and technical efficiency of its members through creating forums for the exchange of ideas and practical experience. Founded in 1980-, the Society now has more than 20,000 members in 90 countries.
The ISPE Europe 2014 conference will be held April 28-30 at the Sheraton Hotel and Conference Center, Frankfurt-am-Main, Germany.
Themed ‘Driving Effectiveness in Pharmaceutical Operations within the New Quality Culture ‘ the conference will bring together pharmaceutical, regulatory and technology experts from around the world.
The two-and-half-day event will consist of an executive forum, keynote sessions and three different tracks to assess how the senior management and operational challenges, quality system effectiveness and regulatory changes can be brought into a new pharmaceutical paradigm to exploit opportunities like Quality-by-Design, continuous manufacturing, science- and risk-based regulations in the daily life.
Conference tracks will include:
- QbD – Reality Today? Implementation and Beyond
- QRM – Quality Risk Management
- Facilities of the Future
Maria Rosén, Marketing Director, Pharmadule Morimatsu AB
Tel: +46 (0)8 587 42 000
Click on Pharmadule brings Modular Concept to ISPE 2014 Frankfurt for other information.
Click on Pharmadule to contact the company directly.